Home / Stocks / ASPIRA
Back to all stocks
BSE · ASPIRA

Aspira Pathlab & Diagnostics Limited (ASPIRA) Share Price

Sector: Healthcare · ISIN: INE500C01017

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,753
of 5,047 stocks
▼ 321W▲ 401M
Peak #2,688 · 02 Oct 2026

Aspira Pathlab & Diagnostics Limited is a microcap company in the Healthcare space and carries a steep earnings multiple that prices in strong future growth, is growing revenue rapidly, and has a subdued return on equity. Ownership as of Jun 2026.

Market Cap
134.84 Cr
P/E Ratio
2,620.00
P/B Ratio
11.03
ROE
0.42%
ROCE
2.86%
Dividend Yield
—
52W High
—
52W Low
—

Quarterly financials

MetricQ2 2026-27Q1 2026-27Q4 2025-26Q3 2025-26
Revenue6.26 Cr6.17 Cr6.52 Cr5.12 Cr
Net Profit-1.16 Cr-3.77 L-68.91 L-1.56 Cr
EPS-1.13-0.04-0.67-1.52
Operating Profit-1.05 Cr5.42 L-58.94 L-1.46 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter
46.58%
Public
53.42%

PUBLIC BREAKDOWN

Individuals
40.77%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

No corporate actions on record for this stock.

Other Healthcare stocks

See all Healthcare stocks →

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs